SCHEMBL5825555

SCHEMBL5825555

Oc1ccc(SCCOc2ccccc2Cl)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.47
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
PKM P14618 1/20 0.46
MAPT P10636 5/20 0.44
HTT P42858 4/20 0.44
HPGD P15428 4/20 0.44
LMNA P02545 4/20 0.44
GAA P10253 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
L3MBTL1 Q9Y468 6/20 0.44
TDP1 Q9NUW8 2/20 0.43
TSHR P16473 1/20 0.42
ALDH1A1 P00352 1/20 0.41
TP53 P04637 2/20 0.41
RXRA P19793 1/20 0.41
RXRB P28702 1/20 0.41
KCNH2 Q12809 1/20 0.41
DRD2 P14416 1/20 0.41
DRD4 P21917 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5825457 0.81 L3MBTL1 (0.47) KDM4EMEN1KMT2AMAPTHPGD
SCHEMBL5824932 0.81 KMT2A (0.52) KDM4EMEN1KMT2APKMMAPT
SCHEMBL5825422 0.81 RAB9A (0.54) KDM4EMEN1KMT2APKMMAPT
SCHEMBL9770447 0.78 BACE1 (0.57) KDM4EMEN1KMT2AMAPTHTT
SCHEMBL5825350 0.77 LMNA (0.47) MEN1KMT2AHTTHPGDLMNA
SCHEMBL10407801 0.76 DRD4 (0.53) MEN1KMT2ALMNASMN1; SMN2L3MBTL1
SCHEMBL9808263 0.74 L3MBTL1 (0.68) MEN1KMT2APKMMAPTHTT
SCHEMBL5824818 0.73 NPC1 (0.57) KMT2AMAPTHTTHPGDLMNA
SCHEMBL5824884 0.73 MEN1 (0.56) KDM4EMEN1KMT2APKMMAPT
SCHEMBL5825466 0.72 MEN1 (0.62) KDM4EMEN1KMT2APKMHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7135466-B2 Quinoline and quinazoline derivatives and drugs containing the same KIRIN BEER KABUSHIKI KAISHA (JP) 2006-11-14 US disclosed
US-20060211717-A1 Quinoline and quinazoline derivatives and drugs containing the same KIRIN BEER KABUSHIKI KAISHA (JP) 2006-09-21 US disclosed
US-20040132727-A1 Quinoline and quinazoline derivatives and drugs containing the same KIRIN HOLDINGS KABUSHIKI KAISHA (JP) 2004-07-08 US disclosed
EP-1243582-A1 QUINOLINE AND QUINAZOLINE DERIVATIVES AND DRUGS CONTAINING THE SAME KIRIN BEER KABUSHIKI KAISHA (JP) 2002-09-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060211717-A1 Quinoline and quinazoline derivatives and drugs containing the same PDGFRA, PDGFRB, PDGFA KDM4E 1657/4885MEN1 3835/4885KMT2A 2022/4885
US-20040132727-A1 Quinoline and quinazoline derivatives and drugs containing the same PDGFRA, PDGFRB, PDGFA KDM4E 1526/4885MEN1 4168/4885KMT2A 2006/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.